(1)
Bin Sabbar, N. S.; Alowirdi, F. S.; Basakran, F. A.; Al-Badr, L. A.; Assiri, R. A.; Alshahrani, W. A.; Althubaiti, A.; Damlaj, M. Addition of Rituximab to Hyper-CVAD Improves Overall Survival in Newly Diagnosed Burkitt leukemia/Lymphoma from the Middle East and North Africa Region. Int J Community Med Public Health 2019, 6, 4199-4203.